142 related articles for article (PubMed ID: 15927999)
21. Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab.
Bendtzen K; Geborek P; Svenson M; Larsson L; Kapetanovic MC; Saxne T
Arthritis Rheum; 2006 Dec; 54(12):3782-9. PubMed ID: 17133559
[TBL] [Abstract][Full Text] [Related]
22. Selective reactivation of human herpesvirus 6 in patients with autoimmune connective tissue diseases.
Broccolo F; Drago F; Cassina G; Fava A; Fusetti L; Matteoli B; Ceccherini-Nelli L; Sabbadini MG; Lusso P; Parodi A; Malnati MS
J Med Virol; 2013 Nov; 85(11):1925-34. PubMed ID: 23983182
[TBL] [Abstract][Full Text] [Related]
23. Infliximab improves vascular stiffness in patients with rheumatoid arthritis.
Wong M; Oakley SP; Young L; Jiang BY; Wierzbicki A; Panayi G; Chowienczyk P; Kirkham B
Ann Rheum Dis; 2009 Aug; 68(8):1277-84. PubMed ID: 18930987
[TBL] [Abstract][Full Text] [Related]
24. Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy.
D'Ovidio V; Vernia P; Gentile G; Capobianchi A; Marcheggiano A; Viscido A; Martino P; Caprilli R
J Clin Virol; 2008 Oct; 43(2):180-3. PubMed ID: 18614396
[TBL] [Abstract][Full Text] [Related]
25. Cytomegalovirus replication and "herpesvirus burden" as risk factor of cardiovascular events in the first year after renal transplantation.
Gómez E; Laurés A; Baltar JM; Melón S; Díez B; de Oña M
Transplant Proc; 2005 Nov; 37(9):3760-3. PubMed ID: 16386530
[TBL] [Abstract][Full Text] [Related]
26. Detection of beta-herpesviruses in allogenic stem cell recipients by quantitative real-time PCR.
Sassenscheidt J; Rohayem J; Illmer T; Bandt D
J Virol Methods; 2006 Dec; 138(1-2):40-8. PubMed ID: 16956672
[TBL] [Abstract][Full Text] [Related]
27. Detection of four lymphotropic herpesviruses in Hungarian patients with multiple myeloma and lymphoma.
Csire M; Mikala G; Peto M; Jánosi J; Juhász A; Tordai A; Jákó J; Domján G; Dolgos J; Berencsi G; Vályi-Nagy I
FEMS Immunol Med Microbiol; 2007 Feb; 49(1):62-7. PubMed ID: 17132141
[TBL] [Abstract][Full Text] [Related]
28. [Herpesviruses mixed infections in allogeneic steam cell recipients (allo-HSCT)].
Zawilińska B; Kosz-Vnenchak M; Piatkowska-Jakubas B; Kopeć J; Daszkiewicz E; Skotnicki AB
Przegl Epidemiol; 2008; 62(1):39-46. PubMed ID: 18536223
[TBL] [Abstract][Full Text] [Related]
29. Drug-induced hypersensitivity syndrome due to cyanamide associated with multiple reactivation of human herpesviruses.
Mitani N; Aihara M; Yamakawa Y; Yamada M; Itoh N; Mizuki N; Ikezawa Z
J Med Virol; 2005 Mar; 75(3):430-4. PubMed ID: 15648066
[TBL] [Abstract][Full Text] [Related]
30. Infliximab treatment reduces complement activation in patients with rheumatoid arthritis.
Familian A; Voskuyl AE; van Mierlo GJ; Heijst HA; Twisk JW; Dijkmans BA; Hack CE
Ann Rheum Dis; 2005 Jul; 64(7):1003-8. PubMed ID: 15958758
[TBL] [Abstract][Full Text] [Related]
31. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
[TBL] [Abstract][Full Text] [Related]
32. Bone mineral density in patients with rheumatoid arthritis treated with infliximab.
Vis M; Voskuyl AE; Wolbink GJ; Dijkmans BA; Lems WF;
Ann Rheum Dis; 2005 Feb; 64(2):336-7. PubMed ID: 15647447
[No Abstract] [Full Text] [Related]
33. [Clinical experience with TNF-alpha inhibitors in rheumatoid arthritis].
Wallenius M; Rødevand E; Skomsvoll JF
Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1664-6. PubMed ID: 15976836
[TBL] [Abstract][Full Text] [Related]
34. Long-term infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders.
Buch MH; Bingham SJ; Bryer D; Emery P
Rheumatology (Oxford); 2007 Jul; 46(7):1153-6. PubMed ID: 17478470
[TBL] [Abstract][Full Text] [Related]
35. Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis.
Kiortsis DN; Mavridis AK; Filippatos TD; Vasakos S; Nikas SN; Drosos AA
J Rheumatol; 2006 May; 33(5):921-3. PubMed ID: 16541480
[TBL] [Abstract][Full Text] [Related]
36. Saliva polymerase chain reaction assay for detection and follow-up of herpesvirus reactivation in patients with drug reaction with eosinophilia and systemic symptoms (DRESS).
Descamps V; Avenel-Audran M; Valeyrie-Allanore L; Bensaid B; Barbaud A; Al Jawhari M; Ranger-Rogez S;
JAMA Dermatol; 2013 May; 149(5):565-9. PubMed ID: 23426332
[TBL] [Abstract][Full Text] [Related]
37. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
38. OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation.
Barkholt L; Linde A; Falk KI
Transpl Int; 2005 Jul; 18(7):835-43. PubMed ID: 15948864
[TBL] [Abstract][Full Text] [Related]
39. Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab.
Toubi E; Kessel A; Mahmudov Z; Hallas K; Rozenbaum M; Rosner I
Ann N Y Acad Sci; 2005 Jun; 1051():506-14. PubMed ID: 16126991
[TBL] [Abstract][Full Text] [Related]
40. Preemptive management of Epstein-Barr virus reactivation after hematopoietic stem-cell transplantation.
Ahmad I; Cau NV; Kwan J; Maaroufi Y; Meuleman N; Aoun M; Lewalle P; Martiat P; Crokaert F; Bron D
Transplantation; 2009 Apr; 87(8):1240-5. PubMed ID: 19384173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
